Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
Biotechnology Equipment

PUBLISHER: Fairfield Market Research | PRODUCT CODE: 1394134

Cover Image

PUBLISHER: Fairfield Market Research | PRODUCT CODE: 1394134

Mammalian Cell Banking Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

PUBLISHED:
PAGES: 251 Pages
DELIVERY TIME: 2-5 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
Unprintable PDF & Excel (Single User License)
USD 4995
Unprintable PDF & Excel (Multi User License upto 5 users)
USD 8495
Printable PDF & Excel (Enterprise License above 5 users)
USD 10600

Add to Cart

Description

Table of Contents

The global Mammalian Cell Banking Market, which was valued at approximately US$ 484 Million in 2024, is projected to experience a remarkable surge, with an anticipated Compound Annual Growth Rate (CAGR) of 16%. By the end of 2033, the market is expected to reach a staggering valuation of around US$ 1400 million, according to the latest market outlook report.

Mammalian cells, derived from mammalian tissues, play a pivotal role in various biotechnology applications, including the production of viruses, proteins, and modeling of biological systems and diseases. The increasing focus on oncological research, coupled with substantial investments from institutions like the National Cancer Institute, is driving the growth of the Mammalian Cell Banking Market.

Increasing Focus on Oncological Research to Boost Market Growth

Cancer research is at the forefront of driving growth in the Mammalian Cell Banking Market. The unique receptivity of cancer cells to in vitro culture has made mammalian cell culture a cornerstone in oncology research. Cell lines offer a continuous supply of biological material crucial for scientific experiments. Furthermore, government agencies in South Asia are actively funding cancer research, which is expanding the market for companies providing mammalian cell banking services.

Barriers to Market Growth: Lack of Skilled Professionals

Despite the promising growth prospects, the Mammalian Cell Banking Market faces challenges, primarily due to a shortage of skilled professionals in research and development. The lack of skilled experts hampers innovation and the generation of new knowledge in the field. Factors such as low salary scales, challenging roles, and insufficient laboratory training contribute to this shortage. Specialized laboratory training courses are essential for handling cell line cultures, but the cost of these courses can deter individuals from pursuing careers in this field, thereby hindering market growth.

Booming U.S. Market

The United States is witnessing a significant boom in the Mammalian Cell Banking Market, driven by the expansion of cancer research. Key manufacturers are focusing on increasing staff productivity, enhancing flexibility, and improving efficiency. Service consolidation activities, including sales and service agreements, collaborations, research and development efforts, new service launches, and mergers & acquisitions by both global and regional players, are shaping the competitive landscape within the U.S. market.

Lucrative Opportunities in India

India presents lucrative opportunities in the Mammalian Cell Banking Market, owing to its growing cancer burden. With over 1 million new cases of cancer reported annually, this number is expected to rise due to demographic changes and lifestyle factors. The Department of Biotechnology (DBT) in India is providing resources for multi-institutional networking programs, individual investigators, and institutions through its Research & Development programs focused on cancer disease. This initiative is set to drive further growth in the Indian market.

Emerging Prominence in Japan

Japan is emerging as a prominent market for specialized cell culture services. The evolving needs of the research community have led to increased demand for customized solutions, as researchers prefer tailored approaches to meet the specific requirements of their projects. Vendors are responding by building robust distribution networks to rapidly deliver services from their manufacturing plants in the region. This emphasis on customization is propelling the growth of the Mammalian Cell Banking Market in Japan.

Competitive Landscape Analysis

Key players in the Mammalian Cell Banking Market are actively pursuing strategies such as product launches, strategic alliances, acquisitions, and facility expansions to strengthen their market presence. These efforts aim to enhance the development of new technologies and innovative research capabilities within the industry.

Key Companies Profiled

  • Eurofins DiscoverX Corporation
  • Merck KGaA
  • Sartorius Stedim BioOutsource Limited
  • Charles River Laboratories
  • Altogen Labs
  • Abzena Ltd
  • Northway Biotechpharma
  • Lonza Group Ltd
  • VIRUSURE
  • Selexis SA
  • Takara Bio Inc

The Mammalian Cell Banking Market is poised for remarkable growth, driven by the imperative role it plays in advancing oncological research and supported by global initiatives. As the market continues to evolve, key players are positioning themselves to meet the increasing demand for specialized cell culture services.

Key Segments Covered in Manufacturing of Industry Research

Cell Type:

  • CHO
  • BHK
  • NS0
  • YB2/0 & P2/0
  • HEK293 & Derivatives
  • HELA

Technology:

  • TEP
  • IEP
  • SEP

Application:

  • MCB
  • WCB
  • EoP
  • R&D CB

End User:

  • Academic & Research Institute
  • Biopharmaceutical Companies
  • CROs

Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • The Middle East & Africa (MEA)
Show more

Table of Contents

1. Executive Summary

  • 1.1. Global Mammalian Cell Banking Market Snapshot
  • 1.2. Future Projections
  • 1.3. Key Market Trends
  • 1.4. Regional Snapshot, by Value, 2023
  • 1.5. Analyst Recommendations

2. Market Overview

  • 2.1. Market Definitions and Segmentations
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Market Opportunities
  • 2.3. Value Chain Analysis
  • 2.4. Porter's Five Forces Analysis
  • 2.5. COVID-19 Impact Analysis
    • 2.5.1. Supply
    • 2.5.2. Demand
  • 2.6. Impact of Ukraine-Russia Conflict
  • 2.7. Economic Overview
    • 2.7.1. World Economic Projections
  • 2.8. PESTLE Analysis

3. Global Mammalian Cell Banking Market Outlook, 2018 - 2031

  • 3.1. Global Mammalian Cell Banking Market Outlook, by Cell Type, Value (US$ Mn), 2018 - 2031
    • 3.1.1. Key Highlights
      • 3.1.1.1. CHO
      • 3.1.1.2. BHK
      • 3.1.1.3. NS0
      • 3.1.1.4. YB2/0 & P2/0
      • 3.1.1.5. HEK293 & Derivatives
      • 3.1.1.6. HELA
  • 3.2. Global Mammalian Cell Banking Market Outlook, by Technology, Value (US$ Mn), 2018 - 2031
    • 3.2.1. Key Highlights
      • 3.2.1.1. TEP
      • 3.2.1.2. IEP
      • 3.2.1.3. SEP
  • 3.3. Global Mammalian Cell Banking Market Outlook, by Application, Value (US$ Mn), 2018 - 2031
    • 3.3.1. Key Highlights
      • 3.3.1.1. MCB
      • 3.3.1.2. WCB
      • 3.3.1.3. EoP
      • 3.3.1.4. R&D CB
  • 3.4. Global Mammalian Cell Banking Market Outlook, by End User, Value (US$ Mn), 2018 - 2031
    • 3.4.1. Key Highlights
      • 3.4.1.1. Academic & Research Institute
      • 3.4.1.2. Biopharmaceutical Companies
      • 3.4.1.3. CROs
  • 3.5. Global Mammalian Cell Banking Market Outlook, by Region, Value (US$ Mn), 2018 - 2031
    • 3.5.1. Key Highlights
      • 3.5.1.1. North America
      • 3.5.1.2. Europe
      • 3.5.1.3. Asia Pacific
      • 3.5.1.4. Latin America
      • 3.5.1.5. Middle East & Africa

4. North America Mammalian Cell Banking Market Outlook, 2018 - 2031

  • 4.1. North America Mammalian Cell Banking Market Outlook, by Cell Type, Value (US$ Mn), 2018 - 2031
    • 4.1.1. Key Highlights
      • 4.1.1.1. CHO
      • 4.1.1.2. BHK
      • 4.1.1.3. NS0
      • 4.1.1.4. YB2/0 & P2/0
      • 4.1.1.5. HEK293 & Derivatives
      • 4.1.1.6. HELA
  • 4.2. North America Mammalian Cell Banking Market Outlook, by Technology, Value (US$ Mn), 2018 - 2031
    • 4.2.1. Key Highlights
      • 4.2.1.1. TEP
      • 4.2.1.2. IEP
      • 4.2.1.3. SEP
  • 4.3. North America Mammalian Cell Banking Market Outlook, by Application, Value (US$ Mn), 2018 - 2031
    • 4.3.1. Key Highlights
      • 4.3.1.1. MCB
      • 4.3.1.2. WCB
      • 4.3.1.3. EoP
      • 4.3.1.4. R&D CB
  • 4.4. North America Mammalian Cell Banking Market Outlook, by End User, Value (US$ Mn), 2018 - 2031
    • 4.4.1. Key Highlights
      • 4.4.1.1. Academic & Research Institute
      • 4.4.1.2. Biopharmaceutical Companies
      • 4.4.1.3. CROs
  • 4.5. North America Mammalian Cell Banking Market Outlook, by Country, Value (US$ Mn), 2018 - 2031
    • 4.5.1. Key Highlights
      • 4.5.1.1. U.S. Mammalian Cell Banking Market by Cell Type, Value (US$ Mn), 2018 - 2031
      • 4.5.1.2. U.S. Mammalian Cell Banking Market By Technology, Value (US$ Mn), 2018 - 2031
      • 4.5.1.3. U.S. Mammalian Cell Banking Market By Application, Value (US$ Mn), 2018 - 2031
      • 4.5.1.4. U.S. Mammalian Cell Banking Market End User, Value (US$ Mn), 2018 - 2031
      • 4.5.1.5. Canada Mammalian Cell Banking Market by Cell Type, Value (US$ Mn), 2018 - 2031
      • 4.5.1.6. Canada Mammalian Cell Banking Market By Technology, Value (US$ Mn), 2018 - 2031
      • 4.5.1.7. Canada Mammalian Cell Banking Market By Application, Value (US$ Mn), 2018 - 2031
      • 4.5.1.8. Canada Mammalian Cell Banking Market End User, Value (US$ Mn), 2018 - 2031
    • 4.5.2. BPS Analysis/Market Attractiveness Analysis

5. Europe Mammalian Cell Banking Market Outlook, 2018 - 2031

  • 5.1. Europe Mammalian Cell Banking Market Outlook, by Cell Type, Value (US$ Mn), 2018 - 2031
    • 5.1.1. Key Highlights
      • 5.1.1.1. CHO
      • 5.1.1.2. BHK
      • 5.1.1.3. NS0
      • 5.1.1.4. YB2/0 & P2/0
      • 5.1.1.5. HEK293 & Derivatives
      • 5.1.1.6. HELA
  • 5.2. Europe Mammalian Cell Banking Market Outlook, by Technology, Value (US$ Mn), 2018 - 2031
    • 5.2.1. Key Highlights
      • 5.2.1.1. TEP
      • 5.2.1.2. IEP
      • 5.2.1.3. SEP
  • 5.3. Europe Mammalian Cell Banking Market Outlook, by Application, Value (US$ Mn), 2018 - 2031
    • 5.3.1. Key Highlights
      • 5.3.1.1. MCB
      • 5.3.1.2. WCB
      • 5.3.1.3. EoP
      • 5.3.1.4. R&D CB
  • 5.4. Europe Mammalian Cell Banking Market Outlook, by End User, Value (US$ Mn), 2018 - 2031
    • 5.4.1. Key Highlights
      • 5.4.1.1. Academic & Research Institute
      • 5.4.1.2. Biopharmaceutical Companies
      • 5.4.1.3. CROs
  • 5.5. Europe Mammalian Cell Banking Market Outlook, by Country, Value (US$ Mn), 2018 - 2031
    • 5.5.1. Key Highlights
      • 5.5.1.1. Germany Mammalian Cell Banking Market by Cell Type, Value (US$ Mn), 2018 - 2031
      • 5.5.1.2. Germany Mammalian Cell Banking Market By Technology, Value (US$ Mn), 2018 - 2031
      • 5.5.1.3. Germany Mammalian Cell Banking Market By Application, Value (US$ Mn), 2018 - 2031
      • 5.5.1.4. Germany Mammalian Cell Banking Market End User, Value (US$ Mn), 2018 - 2031
      • 5.5.1.5. U.K. Mammalian Cell Banking Market by Cell Type, Value (US$ Mn), 2018 - 2031
      • 5.5.1.6. U.K. Mammalian Cell Banking Market By Technology, Value (US$ Mn), 2018 - 2031
      • 5.5.1.7. U.K. Mammalian Cell Banking Market By Application, Value (US$ Mn), 2018 - 2031
      • 5.5.1.8. U.K. Mammalian Cell Banking Market End User, Value (US$ Mn), 2018 - 2031
      • 5.5.1.9. France Mammalian Cell Banking Market by Cell Type, Value (US$ Mn), 2018 - 2031
      • 5.5.1.10. France Mammalian Cell Banking Market By Technology, Value (US$ Mn), 2018 - 2031
      • 5.5.1.11. France Mammalian Cell Banking Market By Application, Value (US$ Mn), 2018 - 2031
      • 5.5.1.12. France Mammalian Cell Banking Market End User, Value (US$ Mn), 2018 - 2031
      • 5.5.1.13. Italy Mammalian Cell Banking Market by Cell Type, Value (US$ Mn), 2018 - 2031
      • 5.5.1.14. Italy Mammalian Cell Banking Market By Technology, Value (US$ Mn), 2018 - 2031
      • 5.5.1.15. Italy Mammalian Cell Banking Market By Application, Value (US$ Mn), 2018 - 2031
      • 5.5.1.16. Italy Mammalian Cell Banking Market End User, Value (US$ Mn), 2018 - 2031
      • 5.5.1.17. Turkey Mammalian Cell Banking Market by Cell Type, Value (US$ Mn), 2018 - 2031
      • 5.5.1.18. Turkey Mammalian Cell Banking Market By Technology, Value (US$ Mn), 2018 - 2031
      • 5.5.1.19. Turkey Mammalian Cell Banking Market By Application, Value (US$ Mn), 2018 - 2031
      • 5.5.1.20. Turkey Mammalian Cell Banking Market End User, Value (US$ Mn), 2018 - 2031
      • 5.5.1.21. Russia Mammalian Cell Banking Market by Cell Type, Value (US$ Mn), 2018 - 2031
      • 5.5.1.22. Russia Mammalian Cell Banking Market By Technology, Value (US$ Mn), 2018 - 2031
      • 5.5.1.23. Russia Mammalian Cell Banking Market By Application, Value (US$ Mn), 2018 - 2031
      • 5.5.1.24. Russia Mammalian Cell Banking Market End User, Value (US$ Mn), 2018 - 2031
      • 5.5.1.25. Rest of Europe Mammalian Cell Banking Market by Cell Type, Value (US$ Mn), 2018 - 2031
      • 5.5.1.26. Rest of Europe Mammalian Cell Banking Market By Technology, Value (US$ Mn), 2018 - 2031
      • 5.5.1.27. Rest of Europe Mammalian Cell Banking Market By Application, Value (US$ Mn), 2018 - 2031
      • 5.5.1.28. Rest of Europe Mammalian Cell Banking Market End User, Value (US$ Mn), 2018 - 2031
    • 5.5.2. BPS Analysis/Market Attractiveness Analysis

6. Asia Pacific Mammalian Cell Banking Market Outlook, 2018 - 2031

  • 6.1. Asia Pacific Mammalian Cell Banking Market Outlook, by Cell Type, Value (US$ Mn), 2018 - 2031
    • 6.1.1. Key Highlights
      • 6.1.1.1. CHO
      • 6.1.1.2. BHK
      • 6.1.1.3. NS0
      • 6.1.1.4. YB2/0 & P2/0
      • 6.1.1.5. HEK293 & Derivatives
      • 6.1.1.6. HELA
  • 6.2. Asia Pacific Mammalian Cell Banking Market Outlook, by Technology, Value (US$ Mn), 2018 - 2031
    • 6.2.1. Key Highlights
      • 6.2.1.1. TEP
      • 6.2.1.2. IEP
      • 6.2.1.3. SEP
  • 6.3. Asia Pacific Mammalian Cell Banking Market Outlook, by Application, Value (US$ Mn), 2018 - 2031
    • 6.3.1. Key Highlights
      • 6.3.1.1. MCB
      • 6.3.1.2. WCB
      • 6.3.1.3. EoP
      • 6.3.1.4. R&D CB
  • 6.4. Asia Pacific Mammalian Cell Banking Market Outlook, by End User, Value (US$ Mn), 2018 - 2031
    • 6.4.1. Key Highlights
      • 6.4.1.1. Academic & Research Institute
      • 6.4.1.2. Biopharmaceutical Companies
      • 6.4.1.3. CROs
  • 6.5. Asia Pacific Mammalian Cell Banking Market Outlook, by Country, Value (US$ Mn), 2018 - 2031
    • 6.5.1. Key Highlights
      • 6.5.1.1. China Mammalian Cell Banking Market by Cell Type, Value (US$ Mn), 2018 - 2031
      • 6.5.1.2. China Mammalian Cell Banking Market By Technology, Value (US$ Mn), 2018 - 2031
      • 6.5.1.3. China Mammalian Cell Banking Market By Application, Value (US$ Mn), 2018 - 2031
      • 6.5.1.4. China Mammalian Cell Banking Market End User, Value (US$ Mn), 2018 - 2031
      • 6.5.1.5. Japan Mammalian Cell Banking Market by Cell Type, Value (US$ Mn), 2018 - 2031
      • 6.5.1.6. Japan Mammalian Cell Banking Market By Technology, Value (US$ Mn), 2018 - 2031
      • 6.5.1.7. Japan Mammalian Cell Banking Market By Application, Value (US$ Mn), 2018 - 2031
      • 6.5.1.8. Japan Mammalian Cell Banking Market End User, Value (US$ Mn), 2018 - 2031
      • 6.5.1.9. South Korea Mammalian Cell Banking Market by Cell Type, Value (US$ Mn), 2018 - 2031
      • 6.5.1.10. South Korea Mammalian Cell Banking Market By Technology, Value (US$ Mn), 2018 - 2031
      • 6.5.1.11. South Korea Mammalian Cell Banking Market By Application, Value (US$ Mn), 2018 - 2031
      • 6.5.1.12. South Korea Mammalian Cell Banking Market End User, Value (US$ Mn), 2018 - 2031
      • 6.5.1.13. India Mammalian Cell Banking Market by Cell Type, Value (US$ Mn), 2018 - 2031
      • 6.5.1.14. India Mammalian Cell Banking Market By Technology, Value (US$ Mn), 2018 - 2031
      • 6.5.1.15. India Mammalian Cell Banking Market By Application, Value (US$ Mn), 2018 - 2031
      • 6.5.1.16. India Mammalian Cell Banking Market End User, Value (US$ Mn), 2018 - 2031
      • 6.5.1.17. Southeast Asia Mammalian Cell Banking Market by Cell Type, Value (US$ Mn), 2018 - 2031
      • 6.5.1.18. Southeast Asia Mammalian Cell Banking Market By Technology, Value (US$ Mn), 2018 - 2031
      • 6.5.1.19. Southeast Asia Mammalian Cell Banking Market By Application, Value (US$ Mn), 2018 - 2031
      • 6.5.1.20. Southeast Asia Mammalian Cell Banking Market End User, Value (US$ Mn), 2018 - 2031
      • 6.5.1.21. Rest of Asia Pacific Mammalian Cell Banking Market by Cell Type, Value (US$ Mn), 2018 - 2031
      • 6.5.1.22. Rest of Asia Pacific Mammalian Cell Banking Market By Technology, Value (US$ Mn), 2018 - 2031
      • 6.5.1.23. Rest of Asia Pacific Mammalian Cell Banking Market By Application, Value (US$ Mn), 2018 - 2031
      • 6.5.1.24. Rest of Asia Pacific Mammalian Cell Banking Market End User, Value (US$ Mn), 2018 - 2031
    • 6.5.2. BPS Analysis/Market Attractiveness Analysis

7. Latin America Mammalian Cell Banking Market Outlook, 2018 - 2031

  • 7.1. Latin America Mammalian Cell Banking Market Outlook, by Cell Type, Value (US$ Mn), 2018 - 2031
    • 7.1.1. Key Highlights
      • 7.1.1.1. CHO
      • 7.1.1.2. BHK
      • 7.1.1.3. NS0
      • 7.1.1.4. YB2/0 & P2/0
      • 7.1.1.5. HEK293 & Derivatives
      • 7.1.1.6. HELA
  • 7.2. Latin America Mammalian Cell Banking Market Outlook, by Technology, Value (US$ Mn), 2018 - 2031
      • 7.2.1.1. TEP
      • 7.2.1.2. IEP
      • 7.2.1.3. SEP
  • 7.3. Latin America Mammalian Cell Banking Market Outlook, by Application, Value (US$ Mn), 2018 - 2031
    • 7.3.1. Key Highlights
      • 7.3.1.1. MCB
      • 7.3.1.2. WCB
      • 7.3.1.3. EoP
      • 7.3.1.4. R&D CB
  • 7.4. Latin America Mammalian Cell Banking Market Outlook, by End User, Value (US$ Mn), 2018 - 2031
    • 7.4.1. Key Highlights
      • 7.4.1.1. Academic & Research Institute
      • 7.4.1.2. Biopharmaceutical Companies
      • 7.4.1.3. CROs
  • 7.5. Latin America Mammalian Cell Banking Market Outlook, by Country, Value (US$ Mn), 2018 - 2031
    • 7.5.1. Key Highlights
      • 7.5.1.1. Brazil Mammalian Cell Banking Market by Cell Type, Value (US$ Mn), 2018 - 2031
      • 7.5.1.2. Brazil Mammalian Cell Banking Market By Technology, Value (US$ Mn), 2018 - 2031
      • 7.5.1.3. Brazil Mammalian Cell Banking Market By Application, Value (US$ Mn), 2018 - 2031
      • 7.5.1.4. Brazil Mammalian Cell Banking Market End User, Value (US$ Mn), 2018 - 2031
      • 7.5.1.5. Mexico Mammalian Cell Banking Market by Cell Type, Value (US$ Mn), 2018 - 2031
      • 7.5.1.6. Mexico Mammalian Cell Banking Market By Technology, Value (US$ Mn), 2018 - 2031
      • 7.5.1.7. Mexico Mammalian Cell Banking Market By Application, Value (US$ Mn), 2018 - 2031
      • 7.5.1.8. Mexico Mammalian Cell Banking Market End User, Value (US$ Mn), 2018 - 2031
      • 7.5.1.9. Argentina Mammalian Cell Banking Market by Cell Type, Value (US$ Mn), 2018 - 2031
      • 7.5.1.10. Argentina Mammalian Cell Banking Market By Technology, Value (US$ Mn), 2018 - 2031
      • 7.5.1.11. Argentina Mammalian Cell Banking Market By Application, Value (US$ Mn), 2018 - 2031
      • 7.5.1.12. Argentina Mammalian Cell Banking Market End User, Value (US$ Mn), 2018 - 2031
      • 7.5.1.13. Rest of Latin America Mammalian Cell Banking Market by Cell Type, Value (US$ Mn), 2018 - 2031
      • 7.5.1.14. Rest of Latin America Mammalian Cell Banking Market By Technology, Value (US$ Mn), 2018 - 2031
      • 7.5.1.15. Rest of Latin America Mammalian Cell Banking Market By Application, Value (US$ Mn), 2018 - 2031
      • 7.5.1.16. Rest of Latin America Mammalian Cell Banking Market End User, Value (US$ Mn), 2018 - 2031
    • 7.5.2. BPS Analysis/Market Attractiveness Analysis

8. Middle East & Africa Mammalian Cell Banking Market Outlook, 2018 - 2031

  • 8.1. Middle East & Africa Mammalian Cell Banking Market Outlook, by Cell Type, Value (US$ Mn), 2018 - 2031
    • 8.1.1. Key Highlights
      • 8.1.1.1. CHO
      • 8.1.1.2. BHK
      • 8.1.1.3. NS0
      • 8.1.1.4. YB2/0 & P2/0
      • 8.1.1.5. HEK293 & Derivatives
      • 8.1.1.6. HELA
  • 8.2. Middle East & Africa Mammalian Cell Banking Market Outlook, by Technology, Value (US$ Mn), 2018 - 2031
    • 8.2.1. Key Highlights
      • 8.2.1.1. TEP
      • 8.2.1.2. IEP
      • 8.2.1.3. SEP
  • 8.3. Middle East & Africa Mammalian Cell Banking Market Outlook, by Application, Value (US$ Mn), 2018 - 2031
    • 8.3.1. Key Highlights
      • 8.3.1.1. MCB
      • 8.3.1.2. WCB
      • 8.3.1.3. EoP
      • 8.3.1.4. R&D CB
  • 8.4. Middle East & Africa Mammalian Cell Banking Market Outlook, by End User, Value (US$ Mn), 2018 - 2031
    • 8.4.1. Key Highlights
      • 8.4.1.1. Academic & Research Institute
      • 8.4.1.2. Biopharmaceutical Companies
      • 8.4.1.3. CROs
  • 8.5. Middle East & Africa Mammalian Cell Banking Market Outlook, by Country, Value (US$ Mn), 2018 - 2031
    • 8.5.1. Key Highlights
      • 8.5.1.1. GCC Mammalian Cell Banking Market by Cell Type, Value (US$ Mn), 2018 - 2031
      • 8.5.1.2. GCC Mammalian Cell Banking Market By Technology, Value (US$ Mn), 2018 - 2031
      • 8.5.1.3. GCC Mammalian Cell Banking Market By Application, Value (US$ Mn), 2018 - 2031
      • 8.5.1.4. GCC Mammalian Cell Banking Market End User, Value (US$ Mn), 2018 - 2031
      • 8.5.1.5. South Africa Mammalian Cell Banking Market by Cell Type, Value (US$ Mn), 2018 - 2031
      • 8.5.1.6. South Africa Mammalian Cell Banking Market By Technology, Value (US$ Mn), 2018 - 2031
      • 8.5.1.7. South Africa Mammalian Cell Banking Market By Application, Value (US$ Mn), 2018 - 2031
      • 8.5.1.8. South Africa Mammalian Cell Banking Market End User, Value (US$ Mn), 2018 - 2031
      • 8.5.1.9. Egypt Mammalian Cell Banking Market by Cell Type, Value (US$ Mn), 2018 - 2031
      • 8.5.1.10. Egypt Mammalian Cell Banking Market By Technology, Value (US$ Mn), 2018 - 2031
      • 8.5.1.11. Egypt Mammalian Cell Banking Market By Application, Value (US$ Mn), 2018 - 2031
      • 8.5.1.12. Egypt Mammalian Cell Banking Market End User, Value (US$ Mn), 2018 - 2031
      • 8.5.1.13. Nigeria Mammalian Cell Banking Market by Cell Type, Value (US$ Mn), 2018 - 2031
      • 8.5.1.14. Nigeria Mammalian Cell Banking Market By Technology, Value (US$ Mn), 2018 - 2031
      • 8.5.1.15. Nigeria Mammalian Cell Banking Market By Application, Value (US$ Mn), 2018 - 2031
      • 8.5.1.16. Nigeria Mammalian Cell Banking Market End User, Value (US$ Mn), 2018 - 2031
      • 8.5.1.17. Rest of Middle East & Africa Mammalian Cell Banking Market by Cell Type, Value (US$ Mn), 2018 - 2031
      • 8.5.1.18. Rest of Middle East & Africa Mammalian Cell Banking Market By Technology, Value (US$ Mn), 2018 - 2031
      • 8.5.1.19. Rest of Middle East & Africa Mammalian Cell Banking Market By Application, Value (US$ Mn), 2018 - 2031
      • 8.5.1.20. Rest of Middle East & Africa Mammalian Cell Banking Market End User, Value (US$ Mn), 2018 - 2031
    • 8.5.2. BPS Analysis/Market Attractiveness Analysis

9. Competitive Landscape

  • 9.1. By Application vs By Technology Heatmap
  • 9.2. Manufacturer vs By Technology Heatmap
  • 9.3. Company Market Share Analysis, 2023
  • 9.4. Competitive Dashboard
  • 9.5. Company Profiles
    • 9.5.1. Eurofins DiscoverX Corporation
      • 9.5.1.1. Company Overview
      • 9.5.1.2. Product Portfolio
      • 9.5.1.3. Financial Overview
      • 9.5.1.4. Business Strategies and Development
    • 9.5.2. Merck KGaA
      • 9.5.2.1. Company Overview
      • 9.5.2.2. Product Portfolio
      • 9.5.2.3. Financial Overview
      • 9.5.2.4. Business Strategies and Development
    • 9.5.3. Sartorius Stedim BioOutsource Limited.
      • 9.5.3.1. Company Overview
      • 9.5.3.2. Product Portfolio
      • 9.5.3.3. Financial Overview
      • 9.5.3.4. Business Strategies and Development
    • 9.5.4. Charles River Laboratories
      • 9.5.4.1. Company Overview
      • 9.5.4.2. Product Portfolio
      • 9.5.4.3. Financial Overview
      • 9.5.4.4. Business Strategies and Development
    • 9.5.5. Altogen Labs
      • 9.5.5.1. Company Overview
      • 9.5.5.2. Product Portfolio
      • 9.5.5.3. Financial Overview
      • 9.5.5.4. Business Strategies and Development
    • 9.5.6. Abzena Ltd
      • 9.5.6.1. Company Overview
      • 9.5.6.2. Product Portfolio
      • 9.5.6.3. Financial Overview
      • 9.5.6.4. Business Strategies and Development
    • 9.5.7. Northway Biotechpharma
      • 9.5.7.1. Company Overview
      • 9.5.7.2. Product Portfolio
      • 9.5.7.3. Financial Overview
      • 9.5.7.4. Business Strategies and Development
    • 9.5.8. Lonza Group Ltd
      • 9.5.8.1. Company Overview
      • 9.5.8.2. Product Portfolio
      • 9.5.8.3. Financial Overview
      • 9.5.8.4. Business Strategies and Development
    • 9.5.9. VIRUSURE
      • 9.5.9.1. Company Overview
      • 9.5.9.2. Product Portfolio
      • 9.5.9.3. Financial Overview
      • 9.5.9.4. Business Strategies and Development
    • 9.5.10. Selexis SA
      • 9.5.10.1. Company Overview
      • 9.5.10.2. Product Portfolio
      • 9.5.10.3. Financial Overview
      • 9.5.10.4. Business Strategies and Development
    • 9.5.11. Takara Bio Inc
      • 9.5.11.1. Company Overview
      • 9.5.11.2. Product Portfolio
      • 9.5.11.3. Financial Overview
      • 9.5.11.4. Business Strategies and Development

10. Appendix

  • 10.1. Research Methodology
  • 10.2. Report Assumptions
  • 10.3. Acronyms and Abbreviations
Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!